Today: 20.Jan.2018
Molybdenum 99 Production for Nuclear Medicine 2010 - 2020 Europe
17.Mar.2015
Rate this item
(0 votes)

AIPES - The radionuclides supply for nuclear medicine is crucially dependent on an unsustainably low number of production reactors and processing facilities in Europe, North America, South-Africa and Asia/Pacific.

Read 683 times Last modified on Thursday, 04 January 2018 17:02

Newsletter Subscription

  • Latest
  • Popular
  • Clinton Crackel, a professional in nuclear energy…
  • Clinton Crackel, a professional in nuclear energy…
  • T.D. Luckery: Evidence indicates an inverse relationship…
  • AIPES - The radionuclides supply for nuclear…
  • G. L. Kulcinski - A good overview…